¾ÆÁ¨´Ù
ÇÁ·Î±×·¥
¿¬»ç
±âÁ¶ °¿¬
´ë±â¾÷ÀÇ ¹ßÇ¥
¼îÆ®ÄÚ½º
Æ®·¹ÀÌ´× ¼¼¹Ì³ª
Âü°¡ÀÚ
½ºÆù¼/Àü½Ã±â¾÷
½ºÆù¼
Àü½Ã±â¾÷ Ç÷ξîÇ÷£
°³ÃÖÁö
Æ÷½ºÅÍ ¹ßÇ¥
¹®ÀÇ
Âü°¡½Åû
¡°À¯·´ ÃÖ°íÀÇ »ý¹°Á¦Á¦ ±â¼ú ÄÁÆÛ·±½º¡±
ÄÁÆÛ·±½º ÇÁ·Î±×·¥
Display of Biologics
»ý¹°Á¦Á¦ÀÇ Àü½Ã
Engineering Antibodies
Ç×üÀÇ ¿£Áö´Ï¾î¸µ
Machine Learning: Part 2
±â°èÇнÀ(ÆÄÆ® 2)
Antibody-Based Therapies
Ç×ü ±â¹Ý Ä¡·á¹ý
Emerging Targets & Approaches
»õ·Î¿î Ç¥Àû°ú ¾îÇÁ·ÎÄ¡
Membrane Protein Targets
¸·´Ü¹éÁú Ç¥Àû
Safety & Efficacy
¾ÈÀü¼º°ú È¿´É
Advancing Multispecifics
´ÙÁ߯¯À̼ºÇ×üÀÇ Áøº¸
Engineering Bispecifics
ÀÌÁ߯¯À̼ºÇ×üÀÇ ¿£Áö´Ï¾î¸µ
Modulating the TME
TME(Á¾¾ç ¹Ì¼¼È¯°æ)ÀÇ Á¶Àý
Innovative CAR T Therapy
Çõ½ÅÀûÀÎ CAR-T ¿ä¹ý
Next-Gen Immunotherapies
Â÷¼¼´ë ¸é¿ªÄ¡·á
Optimisation & Developability
ÃÖÀûÈ¿Í ¹ßÀü¼º
Analytical Characterisation
ºÐ¼® Ư¼º Æò°¡
Protein Stability & Formulation
´Ü¹éÁú ¾ÈÁ¤¼º°ú ¹èÇÕ
Data Science & Engineering
µ¥ÀÌÅÍ »çÀÌ¾ð½º¿Í ¿£Áö´Ï¾î¸µ
Optimising Expression
¹ßÇöÀÇ ÃÖÀûÈ
Process Development
ÇÁ·Î¼¼½º °³¹ß
Intro to Machine Learning
±â°èÇнÀ ÀÔ¹®
Machine Learning: Part 1
±â°èÇнÀ(ÆÄÆ® 1)
Machine Learning: Part 2
±â°èÇнÀ(ÆÄÆ® 2)
Antibody-Based Therapies
Ç×ü ±â¹Ý ¿ä¹ý
Engineering Conjugates
º¹ÇÕüÀÇ ¿£Áö´Ï¾î¸µ
Next-Gen Immunotherapies
Â÷¼¼´ë ¸é¿ªÄ¡·á
Catalog Download